Assessment of Insulin Resistance and Body Composition in Children with Overweight and Obesity: A Pilot Study Using

Bogdan Mihai Pascu1,2,3, Anca Bălănescu1,3, Paul Cristian Bălănescu1

  • 1Pediatric Department, Faculty of Medicine, University of Medicine and Pharmacy "Carol Davila", 030167 Bucharest, Romania.

Medicina (Kaunas, Lithuania)
|September 27, 2025
PubMed

Insights

High insulin resistance (IR) affects over half of overweight children, linked to factors like age and body composition. Bioelectrical impedance analysis (BIA) and lipid ratios show moderate predictive power for identifying IR in pediatric obesity.

Area of Science:

  • Pediatric Endocrinology
  • Metabolic Health
  • Body Composition Analysis

Background:

  • Childhood obesity increases risks for type 2 diabetes and cardiovascular disease via insulin resistance (IR).
  • Standard BMI may not fully capture metabolic risk in children, especially those with atypical body fat distribution (TOFI).
  • Early identification of IR is crucial for preventing long-term health complications.

Purpose of the Study:

  • To determine the prevalence and predictors of IR in overweight/obese children.
  • To evaluate the utility of conventional biomarkers and bioelectrical impedance analysis (BIA) for IR assessment.
  • To explore the role of lipid ratios, fasting glucose, and principal component analysis (PCA) in metabolic phenotyping.

Main Methods:

  • Retrospective analysis of 210 children (aged 1-18) with overweight/obesity.
  • Data collection included anthropometrics, fasting labs, and BIA (Tanita PRO DC430 MA).
  • IR defined as HOMA-IR > 2; ROC analysis used for predictive performance; PCA applied to BIA data.

Main Results:

  • Insulin resistance (IR) was found in 54.8% of the cohort.
  • IR correlated with higher age, pubertal status, ALT, LDL-C, triglycerides, and BIA-derived fat-free mass (FFM), total body water (TBW), and appendicular skeletal muscle mass (PMM).
  • Triglyceride-to-HDL ratio and triglycerides showed moderate predictive power for IR; BIA metrics had similar performance. PCA identified fat-free mass and adiposity axes.

Conclusions:

  • A high prevalence of IR exists in children with excess weight, underscoring the need for early screening.
  • Integrating BIA and composite biomarkers can enhance early detection of metabolic dysfunction.
  • PCA-derived body composition components may refine metabolic phenotyping in pediatric obesity management.

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.1K
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
247
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
225
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
685